Literature DB >> 15330324

Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients.

J Blahová1, K Králiková, V Krcméry, M Babálová, R Menkyna, L Glosová, H Knotková, A Lisková, M Molokácová, A Vaculíková.   

Abstract

The aim of the study was to monitor the prevalence of pathogens and development of resistance in bacteria isolated from bacteremic patients. Five University Clinics and/or Regional Hospitals in the Slovak Republic participated in the study and a total of 421 isolates were collected in the second half of the year 2002. The most prevalent organisms were coagulase-negative staphylococci (CONS) (19%), Staphylococcus aureus (18.3%), among Gram-negative bacteria Escherichia coli (13.3%), Klebsiella pneumoniae (11.4%) and Pseudomonas aeruginosa (7.8%) followed by enterococci, Acinetobacter baumannii and Enterobacter sp. All CONS and S. aureus were susceptible to vancomycin; resistance to oxacillin was observed for 55% of the CONS and only for 4% of S. aureus isolates. A higher prevalence of resistance to erythromycin, clindamycin, gentamicin and ofloxacin was found in CONS in comparison to S. aureus. Enterococcus sp. isolates were fully susceptible to vancomycin and teicoplanin. Gentamicin, amoxicillin/clavulanate, third generation cephalosporins and ciprofloxacin showed good activity against E. coli. Although 17% of K. pneumoniae isolates were resistant to ciprofloxacin, it was the most effective drug against K. pneumoniae; the prevalence of resistance to other antibiotics was rather higher. Gentamicin and ciprofloxacin were the most active against Enterobacter sp. isolates and ceftazidime and meropenem against P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330324     DOI: 10.1179/joc.2004.16.3.269

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  4 in total

1.  Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis.

Authors:  M Taj; T Farzana; T Shah; S Maqsood; S S Ahmed; T S Shamsi
Journal:  J Oncol       Date:  2015-07-28       Impact factor: 4.375

2.  Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.

Authors:  Arun B Karanwal; Bharat J Parikh; Parijat Goswami; Harsha P Panchal; Bhavesh B Parekh; Kaushal B Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04

3.  Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern.

Authors:  Seema Mittal; Pooja Singla; Antariksha Deep; Kiran Bala; Rama Sikka; Meenu Garg; Uma Chaudhary
Journal:  J Pathog       Date:  2016-03-07

4.  Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center

Authors:  Asif Husain Osmani; Adnan Abdul Jabbar; Bilal Hassan
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.